David A. Socks - 28 Apr 2022 Form 3 Insider Report for HilleVax, Inc. (HLVX)

Role: CFO & Chief Business Officer
Issuer symbol: HLVX
Report date: 28 Apr 2022
Net transaction value: $0
Form type: 3
Accepted by SEC: 28 Apr 2022, 21:34:43 UTC
Previous filing: 08 Oct 2021
Next filing: 27 May 2022
SEC filing: View on sec.gov
Reporting owner signature: /s/ Paul Bavier, Attorney-in-fact

Key filing fact

David A. Socks filed Form 3 for HilleVax, Inc. (HLVX) on 28 Apr 2022.

Key facts

This page summarizes David A. Socks's Form 3 filing for HilleVax, Inc. (HLVX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 Apr 2022, 21:34.

Change

Previous filing in this sequence was filed on 08 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HLVX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 769,055
Date: 28 Apr 2022
Ownership: See footnote
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 425,175 shares of restricted stock subject to repurchase by the Issuer.

Footnote F2

Consists of (i) 510,183 shares of common stock held in the David A. Socks 2013 Revocable Trust of which Mr. Socks is a trustee; and (ii) 258,872 shares of common stock held by family trusts for which Mr. Socks is a trustee.

SEC remarks

Exhibit 24 - Power of Attorney.